This inventor holds 1 USPTO granted patent. Top assignee: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Weimin Zhong: Innovator in Lyme Disease Treatment
Introduction
Weimin Zhong is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Lyme disease. His innovative approach has the potential to improve the lives of many affected by this condition.
Latest Patents
Weimin Zhong holds a patent for a medicament designed to treat manifested Lyme disease. This pharmaceutical composition includes an antibody as an active agent, specifically targeting the 24 kDa antigen (OspC). The patent details an antibody that is specific for the sequence shown in SEQ ID NO.2, showcasing his commitment to advancing medical treatments.
Career Highlights
Zhong is affiliated with the Max Planck Society for the Advancement of Science, where he conducts research and develops innovative solutions in the medical field. His work is characterized by a dedication to scientific excellence and a focus on addressing pressing health issues.
Collaborations
Throughout his career, Weimin Zhong has collaborated with esteemed colleagues, including Markus M. Simon and Reinhard Wallich. These partnerships have fostered a collaborative environment that enhances the research and development of new medical treatments.
Conclusion
Weimin Zhong's contributions to the treatment of Lyme disease through his innovative patent reflect his dedication to improving healthcare. His work at the Max Planck Society and collaborations with other experts further underscore his impact in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile